Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
Top Cited Papers
- 5 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 28 (3), 319-325
- https://doi.org/10.1038/s41594-021-00570-0
Abstract
The COVID-19 pandemic caused by nonstop infections of SARS-CoV-2 has continued to ravage many countries worldwide. Here we report that suramin, a 100-year-old drug, is a potent inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) and acts by blocking the binding of RNA to the enzyme. In biochemical assays, suramin and its derivatives are at least 20-fold more potent than remdesivir, the currently approved nucleotide drug for treatment of COVID-19. The 2.6 Å cryo-electron microscopy structure of the viral RdRp bound to suramin reveals two binding sites. One site directly blocks the binding of the RNA template strand and the other site clashes with the RNA primer strand near the RdRp catalytic site, thus inhibiting RdRp activity. Suramin blocks viral replication in Vero E6 cells, although the reasons underlying this effect are likely various. Our results provide a structural mechanism for a nonnucleotide inhibitor of the SARS-CoV-2 RdRp.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (2019SHZDZX02)
This publication has 36 references indexed in Scilit:
- Structural Bases of Norovirus RNA Dependent RNA Polymerase Inhibition by Novel Suramin-Related CompoundsPLOS ONE, 2014
- The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivoEmerging Microbes & Infections, 2014
- Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich's vision of chemotherapyTrends in Parasitology, 2013
- Structure-Based Inhibition of Norovirus RNA-Dependent RNA PolymerasesJournal of Molecular Biology, 2012
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa crystallographica. Section D, Structural biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa crystallographica. Section D, Structural biology, 2009
- Human African trypanosomiasisThe Lancet, 2009
- Coot: model-building tools for molecular graphicsActa crystallographica. Section D, Structural biology, 2004
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Symposium on onchocerciasis III. Chemotherapy of onchocerciasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1958